.jpg)
.jpg)
.jpg)
STAT+: FDA Commissioner Marty Makary announces three new hires in leadership team
The commissioner of the FDA welcomed three new leaders to the agency this week, including a new deputy commissioner.
WASHINGTON — The commissioner of the Food and Drug Administration welcomed three new leaders to the agency this week, including a new deputy commissioner, according to an email to staff on Monday.
The new arrivals were Lowell Zeta as deputy commissioner for strategic initiatives; Timothy Schell as acting director for the Center for Veterinary Medicine; and Craig Taylor as the acting chief information officer.
The hires begin to fill the leadership void caused by the departures of high-level FDA officials in recent months. Some left by choice, while others were let go as part of an early April reduction in force across the Health and Human Services Department.
Zeta served as a senior adviser to the commissioner during the first Trump administration, when Stephen Hahn was FDA commissioner. He helped lead the FDA’s 2020 initiative to evaluate its Covid-19 response and better prepare to respond to future pandemics. He was previously a partner at the law firm Hogan Lovells, and helped current Commissioner Marty Makary start to assemble a leadership team in January.
